User:Dashdon/Cervical screening/00ik00 Peer Review

General info

 * Whose work are you reviewing?

Dashdon


 * Link to draft you're reviewing
 * User:Dashdon/Cervical screening


 * Link to the current version of the article (if it exists)
 * Cervical screening

Evaluate the drafted changes
* Notes for sections edited by UCSF SOM Inquiry In Action-- Wikipedia Editing 2022 team.

General*
The addition of a table in the Types of Screening section is a great visual aid and clarifying way of presenting the information. The information about co-testing and recommendations makes this page more complete. This page is written in a neutral perspective and does not attempt to create an argument, persuade the reader, or hint at the opinions of the authors. This page could be improved by reordering the sections to be Types of screening--> Screening process--> Recommendations--> Testing in resource-poor areas--> Emerging technology. The different types of testing are referred to throughout all of the other sections, so it would be helpful to establish/clarify them initially.

Lead*
The lead does a concise job of laying out the information to come. It could be improved by mentioning the newly added type of screening co-testing and emerging technology in cervical screening. Also, it would be helpful to explain what secondary prevention is or to use simpler terminology.

Recommendations*
This section could be improved by adding specific information about a primarily non-English-speaking or non-European country's screening recommendations.

Separate Australian and Canadian recommendations into their own bullet points.

Screening Process
Removal of abnormal cells does not seem like a topic that should be a subsection of screening process.

Types of Screening*
This section could be improved by explaining what specificity and sensitivity are at the beginning of this section. The terms specificity and sensitivity may be inaccessible to the average reader without clarification.

Conventional Cytology
What kind of evaluation is done to the sample in a laboratory?

Human Papillomavirus Testing
This section could be improved by explaining what CIN2, CIN3, CIN2+ refer to. This section could be improved by defining a colposcopy.

Co-testing*
How is immediate CIN risk determined?

Testing in resource-poor areas
Please describe the new test referred to in the first paragraph in more detail.

Do "DNA test" and "HPV test" refer to the same test? If so, please use consistent terminology or provide clarification.

Emerging Technology
The second paragraph in this section has punctuation and sentence-structure errors that make it difficult to understand.

Is one of these emerging technologies the new test mentioned in the Testing in resource-poor areas section? If so, please make that clear. If not, please mention that test in this section with additional information.